Debra Yu

Debra Yu

Director/Board Member chez JW (CAYMAN) THERAPEUTICS CO. LTD

Fortune : 323 000 $ au 31/03/2024

59 ans
Finance
Health Technology
Commercial Services

Profil

Debra Yu is an Independent Director at MeiraGTx Holdings Plc, an Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., and an Independent Director at ARYA Sciences Acquisition Corp.
V.
She is also an Advisor at JDRF International, Treasurer at Institute for Advanced Study, Inc., and General Manager at Shanghai Lianbio Development Co., Ltd.
In the past, she worked as a Senior Director at Pfizer Venture Investments LLC, Managing Director at Bay City Capital LLC, Director at Permanente Co., Director at The BayHelix Group, Managing Director at Labrador Advisors LLC, MD & Head-Cross Border Healthcare Investment at China Renaissance Securities (US), Inc., Consultant at McKinsey & Co., Inc., Principal at Wilkerson Group and Morgan Stanley Venture Partners, General Partner at Delphi Ventures, Inc., and Senior Vice President-Global Business Development at Ascendancy Healthcare, Inc. She was also Vice President-Strategy at Wuxi Apptec, Inc. and President & Chief Strategy Officer at LianBio.
Dr. Yu received her undergraduate degree from Princeton University and her doctorate from Harvard Medical School.
Currently, Dr. Yu is an Independent Director at MeiraGTx Holdings Plc, an Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd., and an Independent Director at ARYA Sciences Acquisition Corp.
V.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/04/2023 1 000 000 ( 0,95% ) 323 000 $ 31/03/2024
08/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Debra Yu

SociétésPosteDébut
ARYA SCIENCES ACQUISITION CORP V Director/Board Member 01/07/2021
MEIRAGTX HOLDINGS PLC Director/Board Member 25/04/2022
JW (CAYMAN) THERAPEUTICS CO. LTD Director/Board Member 01/03/2023
Chief Executive Officer -
Treasurer -
Corporate Officer/Principal -
Tous les postes actifs de Debra Yu

Anciens postes connus de Debra Yu

SociétésPosteFin
LIANBIO President 01/01/2023
The BayHelix Group Director/Board Member 01/01/2020
Corporate Officer/Principal 01/09/2019
░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Debra Yu

Formation de Debra Yu

Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Debra Yu

Relations

100 +

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
MEIRAGTX HOLDINGS PLC

Health Technology

JW (CAYMAN) THERAPEUTICS CO. LTD

Health Technology

LIANBIO

Health Technology

Entreprise privées16

Finance

Commercial Services

Health Services

Finance

Finance

Finance

Finance

Commercial Services

Commercial Services

Permanente Co.

The BayHelix Group

Health Technology

Technology Services

Finance

Health Technology

Labrador Advisors LLC

Voir les connexions sociétés